Large-cell neuroendocrine carcinoma of the ampulla of Vater

Medical Oncology

Volumn 27, Issue 4, 2010, Pages 1144-1148

  Stojsic, Z ^a,b   Brasanac, D ^a   Bilanovic, D ^b   Mitrovic, O ^a   Stevanovic, R ^a   Boricic, I ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Clinical and Hospital Center Bezanijska Kosa   (Serbia)

Author keywords

Ampulla of Vater; Immunohistochemistry; Large cell; Neuroendocrine carcinoma

Indexed keywords

CHROMOGRANIN A; CYTOKERATIN 20; CYTOKERATIN 7; CYTOKERATIN 8; GENE PRODUCT; HISTONE DEACETYLASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; KI 67 ANTIGEN; NEURON SPECIFIC ENOLASE; PANCYTOKERATIN; PROTEIN HMB 45; PROTEIN PGP 9.5; PROTEIN S 100; SOMATOSTATIN; SYNAPTOPHYSIN; THYROID TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG; UVOMORULIN;

ADULT; ARTICLE; CANCER GROWTH; CASE REPORT; CELL NUCLEUS; ENZYME ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LIVER METASTASIS; MALE; MITOSIS; NEUROENDOCRINE TUMOR; PANCREATICODUODENECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TUMOR CELL; TUMOR NECROSIS; VATER PAPILLA CARCINOMA;

AMPULLA OF VATER; CARCINOMA, LARGE CELL; CARCINOMA, NEUROENDOCRINE; COMMON BILE DUCT NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; MALE; MIDDLE AGED; PANCREATICODUODENECTOMY; TUMOR MARKERS, BIOLOGICAL;

EID: 79951767427     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9350-5     Document Type: Article

References (28)

1. Travis WD, et al. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol. 1991;15:529-53.
2. Travis WD. The concept of pulmonary neuroendocrine tumors. In: Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC, editors. World health organization classification of tumors. Pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004. p. 19-20.
3. Capella C, Solcia E, Sobin LH, Arnold R. Endocrine tumors of the stomach. In: Hamilton SR, Aaltonen LA, editors. World health organization classification of tumors. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press; 2000. p. 53-7.
4. Capella C, Solcia E, Sobin LH, Arnold R. Endocrine tumours of the small intestine. In: Hamilton SR, Aaltonen LA, editors. World health organization classification of tumors. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press; 2000. p. 77-82.
5. Capella C, Solcia E, Sobin LH, Arnold R. Endocrine tumors of the colon and rectum. In: Hamilton SR, Aaltonen LA, editors. World health organization classification of tumors. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press; 2000. p. 137-9.
6. Kloppel G, Rindi G, Anlauf M, Perren A, Komminoth P. Sitespecific biology and pathology of gastroenteropancreatic neuroendocrine tumors. Virchows Arch. 2007;451(1):S9-27. (Pubitemid 47283382)
7. Shia J, et al. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity? Am J Surg Pathol. 2008;32:719-31. (Pubitemid 351600819)
8. Boo YJ, et al. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of e-cadherin and Ki-67 as prognostic markers. J Surg Oncol. 2007;95:110-7.
9. Matsui K, Jin XM, Kitagawa M, Miwa A. Clinicopathologic features of neuroendocrine carcinomas of the stomach. Appraisal of small cell and large cell variants. Arch Pathol Lab Med. 1998;122:1010-7. (Pubitemid 28521049)
10. Jiang SX, et al. Gastric large cell neuroendocrine carcinomas: a distinct clinicopathologic entity. Am J Surg Pathol. 2006;30:945-53.
11. Bernick PE, et al. Neuroendocrine carcinomas of the colon and rectum. Dis Colon Rectum. 2004;47:163-9. (Pubitemid 38166619)
12. Kato T, et al. Cytokeratin 20-positive large cell neuroendocrine carcinoma of the colon. Pathol Int. 2005;55:524-9. (Pubitemid 41097856)
13. Emory RE, Emory TS, Goellner JR, Grant CS, Nagorney DM. Neuroendocrine ampullary tumors: spectrum of disease including the first report of a neuroendocrine carcinoma of non-small cell type. Surgery. 1994;115:762-6. (Pubitemid 24189775)
14. Nassar H, Albores-Saavedra J, Klimstra DS. High-grade neuroendocrine carcinoma of the ampulla of Vater. A clinicopathologic and immunohistochemical analysis of 14 cases. Am J Surg Pathol. 2005;29:588-94. (Pubitemid 40577867)
15. Selvakumar E, et al. Large cell neuroendocrine carcinoma of the ampulla of Vater. Hepatobiliary Pancreat Dis Int. 2006;5:465-7. (Pubitemid 44295208)
16. Cavazza A, Gallo M, Valcavi R, De Marco L, Gardini G. Large cell neuroendocrine carcinoma of the ampulla of Vater. Arch Pathol Lab Med. 2003;127:221-3. (Pubitemid 36231772)
17. Hartel M, et al. Large cell neuroendocrine carcinoma of the major duodenal papilla: case report. Gastrointest Endosc. 2004;60:838-41. (Pubitemid 39550954)
18. Huang SS, et al. Large cell neuroendocrine carcinoma of the ampulla of Vater: report of a case. Surg Today. 2006;36:1032-5.
19. Cheng SP, Yang TL, Chang KM, Liu CL. Large cell neuroendocrine carcinoma of the ampulla of Vater with glandular differentiation. J Clin Pathol. 2004;57:1098-100.
20. Nikfarjam M, McLean C, Muralidharan V, Christophi C. Neuroendocrine tumours of the ampulla of Vater. ANZ J Surg. 2002;72:531-3. (Pubitemid 34779387)
21. Liu SH, Tsay SH. Coexistence of large cell neuroendocrine carcinoma and adenocarcinoma of the ampulla of Vater. J Chin Med Assoc. 2008;71:536-40.
22. Brasanac D, Boricic I, Todorovic V, Tomanovic N. Primary cutaneous carcinosarcoma: case report with expanded immunohistochemical analysis. Int J Dermatol. 2008;47:496-501. (Pubitemid 351560318)
23. Sarker AB, et al. An immunohistochemical and ultrastructural study of case of small-cell neuroendocrine carcinoma in the ampullary region of the duodenum. Acta Pathol Jpn. 1992;4:529-35.
24. Shim CS, et al. Neuroendocrine carcinoma of the ampulla of Vater. Gastrointest Endosc. 2000;51:593. (Pubitemid 30322346)
25. Minucci S, Pelicci PG. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer. 2006;6:38-51. (Pubitemid 43054973)
26. Burgess A, et al. Histone deacetylase inhibitors specifically kill nonproliferating tumour cells. Oncogene. 2004;23:6693-701. (Pubitemid 39280001)
27. Baradari V, Huether A, Hopfner M, Schuppan D, Scherubl H. Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells. Endocr Relat Cancer. 2006;13:1237-50. (Pubitemid 46212577)
28. Platta CS, Greenblatt DY, Kunnimalaiyaan M, Chen H. Valproic acid induces notch1 signaling in small cell lung cancer cells. J Surg Res. 2008;148:31-7.